Ace investor Porinju Veliyath shares his outlook for the Indian stock market in 2026, highlighting the importance of stock-specific opportunities and selective investing.
Corona Remedies Ltd. has fixed its price band for the upcoming initial public offering, with the IPO set to open on Dec. 8. Here are the key details investors need to know.
The NSE Nifty 50 and the BSE Sensex settled off day’s lows as HDFC Bank Ltd., ICICI Bank Ltd. shares recovered. Meanwhile, the Indian currency also settled off the record lower against the US dollar.
Manipal Health Enterprises Pvt. is set to file for a $1 billion initial public offering in January, making it the biggest such listing by a hospital operator in India. Here’s what Indian investors need to know.
Copper prices have surged to a fresh record high, driven by strong demand from Asian warehouses. What does this mean for Indian investors and the broader commodity market?
Get the latest updates on the ICICI Prudential AMC IPO, including the launch date, valuation, and what it means for Indian investors.
Dr. Reddy’s Laboratories has secured approval to manufacture and market Semaglutide, a crucial drug for weight loss and diabetes, marking a significant shift in India’s pharmaceutical landscape.
Tata Capital has settled a case with SEBI concerning the issuance of unlisted Cumulative Redeemable Preference Shares (CRPSs) and paid Rs 14.4 lakh. Learn more about this regulatory violation and how it affects Indian investors.
SEBI has given the final approval for the initial public offerings of four companies, including ICICI Prudential Asset Management Co. and Powerica Ltd. Here’s what investors need to know.
The government’s plan to sell up to 6% stake in Bank of Maharashtra via an offer-for-sale (OFS) is expected to increase public shareholding and improve the bank’s capital adequacy. Here’s what it means for investors.